Atlas Trials

Transplant-Related Hematologic Malignancy

7 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Transplant-Related Hematologic Malignancy

RecordFirmDate
GM-CSF With Post-Transplant Cyclophosphamide (NCT04237623)Northside Hospital, Inc.2020-05-18
Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant (NCT03131934)University College, London2019-05-31
Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole (NCT03434704)Ciceri Fabio2018-06-18
Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT (NCT03963024)IRCCS San Raffaele2014-02-12
Transplantation of Hematopoietic Progenitors From Haploidentical Donor With Selective in Vitro Depletion Allo-reactive Lymphocytes in Patient With High Risk Hematological Malignancies (NCT01751243)Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud2013-01-01
Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant (NCT03961919)Ciceri Fabio2009-02-10

Track Transplant-Related Hematologic Malignancy automatically

Every clearance here is in the API, with alerts when new ones post.